New alert for GLP-1 agonist shortages

Supply of most GLP-1 agonists will continue to be constrained until at least the end of 2024, prescribers have been warned, as a result of increased demand for 'licensed and off-label indications'.

by Chloe Harman

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us



  • Limited free articles a month 
  • Free email bulletins

Register Now

Take a 30-day trial

  • Join MIMS now and pay nothing for the first 30 days

Sign Up